Signal pathway involved in the development of hypoxic preconditioning in rat hepatocytes

被引:98
作者
Carini, R
De Cesaris, MG
Splendore, R
Vay, D
Domenicotti, C
Nitti, MP
Paola, D
Pronzato, MA
Albano, E
机构
[1] Univ A Avogadro E Piedmont, Dept Med Sci, I-28100 Novara, Italy
[2] Univ Genoa, Dept Expt Med, Genoa, Italy
关键词
D O I
10.1053/jhep.2001.21050
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Ischemic preconditioning improves liver resistance to hypoxia and reduces reperfusion injury following transplantation. However, the intracellular signals that mediate the development of liver hypoxic preconditioning are largely unknown. We have investigated the signal pathway leading to preconditioning in freshly isolated rat hepatocytes. Hepatocytes were preconditioned by 10-minute incubation under hypoxic conditions followed by 10 minutes of reoxygenation and subsequently exposed to 90 minutes of hypoxia. Preconditioning reduced hepatocyte killing by hypoxia by about 35%. A similar protection was also obtained by preincubation with chloro-adenosine or with A(2A)-adenosine receptor agonist CGS21680, whereas Al-adenosine receptor agonist N-phenyl-isopropyladenosine (R-PIA) was inactive. Conversely, the development of preconditioning was blocked by A(2)-receptor antagonist 3,7-dimethyl-1-propargylxanthine (DMPX), but not by A(1)-receptor antagonist 8-cyclopenthyl-1,3-dipropylxanthine (DPCPX), In either preconditioned or CGS21680-treated hepatocytes a selective activation of delta and epsilon protein kinase C (PKC) isoforms was also evident. Inhibition of heterotrimeric Gi protein or of phospholypase C by, respectively, pertussis toxin or U73122, prevented PKC activation as well as the development of preconditioning. MEK inhibitor PD98509 did not interfere with preconditioning that was instead blocked by p38 MAP kinase inhibitor SB203580, The direct activation of p38 MAPK by anisomycin A mimicked the protection against hypoxic injury given by preconditioning, Consistently, an increased phosphorylation of p38 MAPK was observed in preconditioned or CGS21680-treated hepatocytes, and this effect was abolished by PKC-blocker, chelerythrine. We propose that a signal pathway involving A(2A)-adenosine receptors, G(i)-proteins, phospholypase C, delta- and epsilon -PKCs, and p38 MAPK, is responsible for the development of liver ischemic preconditioning.
引用
收藏
页码:131 / 139
页数:9
相关论文
共 44 条
  • [1] Contribution of adenosine A2 receptors and cyclic adenosine monophosphate to protective ischemic preconditioning of sinusoidal endothelial cells against storage/reperfusion injury in rat livers
    Arai, M
    Thurman, RG
    Lemasters, JJ
    [J]. HEPATOLOGY, 2000, 32 (02) : 297 - 302
  • [2] Protein tyrosine kinase is downstream of protein kinase C for ischemic preconditioning's anti-infarct effect in the rabbit heart
    Baines, CP
    Wang, L
    Cohen, MV
    Downey, JM
    [J]. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1998, 30 (02) : 383 - 392
  • [3] Ischemic preconditioning depends on interaction between mitochondrial KATP channels and actin cytoskeleton
    Baines, CP
    Liu, GS
    Birincioglu, M
    Critz, SD
    Cohen, MV
    Downey, JM
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1999, 276 (04): : H1361 - H1368
  • [4] ALTERATION OF NA+ HOMEOSTASIS AS A CRITICAL STEP IN THE DEVELOPMENT OF IRREVERSIBLE HEPATOCYTE INJURY AFTER ADENOSINE-TRIPHOSPHATE DEPLETION
    CARINI, R
    BELLOMO, G
    BENEDETTI, A
    FULCERI, R
    GAMBERUCCI, A
    PAROLA, M
    DIANZANI, MU
    ALBANO, E
    [J]. HEPATOLOGY, 1995, 21 (04) : 1089 - 1098
  • [5] Ischemic preconditioning reduces Na+ accumulation and cell killing in isolated rat hepatocytes exposed to hypoxia
    Carini, R
    De Cesaris, MG
    Splendore, R
    Bagnati, M
    Albano, E
    [J]. HEPATOLOGY, 2000, 31 (01) : 166 - 172
  • [6] SB-203580 IS A SPECIFIC INHIBITOR OF A MAP KINASE HOMOLOG WHICH IS STIMULATED BY CELLULAR STRESSES AND INTERLEUKIN-1
    CUENDA, A
    ROUSE, J
    DOZA, YN
    MEIER, R
    COHEN, P
    GALLAGHER, TF
    YOUNG, PR
    LEE, JC
    [J]. FEBS LETTERS, 1995, 364 (02) : 229 - 233
  • [7] CUNHA RA, 1999, N-S ARCH PHARMACOL, V359, P259
  • [8] Tissue distribution of adenosine receptor mRNAs in the rat
    Dixon, AK
    Gubitz, AK
    Sirinathsinghji, DJS
    Richardson, PJ
    Freeman, TC
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1996, 118 (06) : 1461 - 1468
  • [9] ADENOSINE AND THE ANTI-INFARCT EFFECTS OF PRECONDITIONING
    DOWNEY, JM
    LIU, GS
    THORNTON, JD
    [J]. CARDIOVASCULAR RESEARCH, 1993, 27 (01) : 3 - 8
  • [10] Stress-activated protein kinases in cardiovascular disease
    Force, T
    Pombo, CM
    Avruch, JA
    Bonventre, JV
    Kyriakis, JM
    [J]. CIRCULATION RESEARCH, 1996, 78 (06) : 947 - 953